# K142999: EVac 70 Xtra Plasma Wand with Integrated Cable, PROcise XP Plasma Wand with Integrated Cable

- Pathway: 510(k) (Special)
- Applicant: ArthroCare Corporation
- Decided: Nov 19, 2014 after 33 days
- Product code: GEI (Electrosurgical, Cutting & Coagulation & Accessories)
- Device class: 2
- Regulation: 21 CFR 878.4400
- Recalls of this device: 3 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 12 generations back to K936109 (1994). 57 ancestors in all.
4 later devices descend from it; 2 cite it directly.
0 of 62 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K070374: Arthrocare Ent Plasma Wand, Arthrocare Corp. (2007) Summary page 5.

## Most influential descendants
- K202006: ENT Plasma Wands, Turbinator Wand, Werewolf Irrigation Tube Set, Werewolf ENT Adapter, Werewolf Coblation System (2020), 2 descendants of its own
- K253680: LYNX COBLATION Laryngeal Wand (72290254) (2026), 0 descendants of its own
- K230914: ARIS¿ COBLATION¿ Turbinate Reduction Wand (72290113); WEREWOLF COBLATION System (72290144); WEREWOLF+ COBLATION System (72290146) (2023), 0 descendants of its own
- K172647: Reprocessed ArthroCare ENT Coblator (2018), 0 descendants of its own

## Recalls of this device
- Jun 2, 2015 · Class II · Z-2105-2015: Wands inspected with the adaptor fixture were released to the field not meeting the dielectric (Hipot) specifications.
- May 15, 2015 · Class II · Z-1832-2015: Potential component failure causing device inoperability
- May 15, 2015 · Class II · Z-1833-2015: Potential component failure resulting in inoperability

## Indications for use
The ArthroCare ENT Plasma Wands are indicated for ablation, resection, and coagulation of soft tissue and hemostasis of blood vessels in otorhinolaryngology (ENT) surgery including: • Adenoidectomy • Cysts • Head, Neck, Oral, and Sinus Surgery • Mastoidectomy • Myringotomy with Effective Hemorrhage Control • Nasal Airway Obstruction by Reduction of Hypertrophic Nasal Turbinates • Nasopharyngeal/Laryngeal Indications including Tracheal Procedures, Laryngeal Polypectomy, and Laryngeal Lesion Debulking • Neck Mass • Papilloma Keloids • Submucosal Palatal Shrinkage • Submucosal Tissue Shrinkage • Tonsillectomy (including palatine tonsils) • Traditional Uvulopalatoplasty (RAUP) • Tumors • Tissue in the Uvula/Soft Palate for the Treatment Of Snoring

Source page: https://510kreport.com/device/K142999
Methodology: https://510kreport.com/methodology